| 000 | 03754nam a22004335i 4500 | ||
|---|---|---|---|
| 999 |
_c382019 _d382019 _x1 |
||
| 001 | 382019 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102121947.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 220924s2022 sz | s |||| 0|eng d | ||
| 020 | _a9783030939908 | ||
| 024 | 7 |
_a10.1007/978-3-030-93990-8 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC642 _b2022 EB |
|
| 245 | 0 | 0 |
_aAdvances in Hemophilia Treatment : _bFrom Genetics to Joint Health _cedited by E. Carlos Rodríguez-Merchán |
| 250 | _aFirst edition 2022 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2022 |
|
| 300 |
_a1 recurso en línea (VIII, 173 páginas) _b42 ilustraciones, 31 ilustraciones a color |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 505 | 0 | _a1. Pathophysiology of hemophilia -- 2. Genetics of Hemophilia A and B -- 3. Inhibitors in Hemophilia A -- 4. Immune Tolerance In Patients with Hemophilia A -- 5. Hemophilia A: New drugs -- 6. Inhibitors in Hemophilia B -- 7. Immune Tolerance Induction in Hemophilia B -- 8. Hemophilia B: New Drugs -- 9. Management of Hemophilia Carriers -- 10. Pharmacoeconomic Aspects in Hemophilia -- 11. Assessment of Joint Health and Outcome Measures in Hemophilia -- 12. Musculoskeletal Medicine in Hemophilia -- 13. Management of Acute Hemarthrosis in Hemophilia (Including Joint Aspiration) -- 14. Hemophilic Arthropathy: Radiosynovectomy -- 15. Hemophilic Arthropathy: Arthroscopic Joint Debridement -- 16. Hemophilic Arthropathy: Total Joint Arthroplasty -- 17. Hemophilic Arthropathy: Other Orthopedic Procedures -- 18. Gene Therapy in Hemophilia: Latest Advances -- 19.A Summary of the Recent Recommendations of the WFH. | |
| 520 | _aThis book offers a comprehensive and state of the art overview of hemophilia management by reviewing all most recent advances and cutting edge information in this fast evolving field. As hemophilia patients are often affected by joint problems it also provides clear guidance on the surgical treatment of musculo-skeletal manifestations. The first part is devoted to the disease's pathophysiology (differentiating hemophilia A and B), genetics, pharmacotherapy - including replacement and non-replacement therapy - and gene therapy, as well as quality of life issues - also related to hemophilia carriers. The second part is then focused on joint problems, ranging from joint health assessment and pain control to surgical treatment of acute hemarthrosis and hemophilic arthropathy, i.e. radiosynovectomy, total joint arthroplasty and arthroscopic joint debridement. Written by experts drawn from leading institutions involved in treatment of hemophilia and related joint problems, this book offers a valuable resource to hematologists, orthopedic surgeons, rehabilitation physicians, radiologists, and pharmacy researchers. | ||
| 988 | _aSpringer_Medicine_2022 | ||
| 650 | 7 |
_2embne _9672556 _aHemofilia |
|
| 650 | 7 |
_2embne _9168800 _aArticulaciones _xEnfermedades |
|
| 700 | 1 |
_aRodríguez-Merchán, E. Carlos _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030939892 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030939915 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030939922 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-93990-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b09/2022 _dz _eIG _zSI |
||